0.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SCYX?
Forum
Prognose
Aktiensplit
Scynexis Inc Aktie (SCYX) Neueste Nachrichten
Can SCYNEXIS Inc. (135A) stock attract analyst upgradesMarket Trend Review & Risk Managed Investment Strategies - newser.com
Is SCYNEXIS Inc. stock ready for a breakoutInflation Watch & Risk Controlled Stock Pick Alerts - newser.com
SCYNEXIS’s (SCYX) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Key facts: GSK Acquires 3.5M Shares; Settles $22M Dispute with Scynexis - TradingView
What MACD signals say about SCYNEXIS Inc.Weekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Building trade automation scripts for SCYNEXIS Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Using R and stats models for SCYNEXIS Inc. forecasting2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
SCYNEXIS, Inc. and GlaxoSmithKline Intellectual Property (No. 3) Limited Enter into Binding Memorandum of Understanding for Amendment to Exclusive License Agreement - MarketScreener
SCYNEXIS receives $22 million from GSK as MARIO study ends - Investing.com
SCYNEXIS (SCYX) Secures $22 Million from GlaxoSmithKline Settlem - GuruFocus
SCYNEXIS and GSK Amend License Agreement - TipRanks
Scynexis to receive $24.3 million from GSK as MARIO study ends per new agreement - Investing.com
SCYNEXIS to Receive $22 Million Payment from GSK Following MARIO Study Termination - Quiver Quantitative
Scynexis and GSK resolve their disagreement related to the restart of the phase 3 MARIO Study - MarketScreener
SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study - The Manila Times
Published on: 2025-10-15 06:26:13 - newser.com
Why SCYNEXIS Inc. stock remains resilientTrade Risk Assessment & Consistent Growth Equity Picks - newser.com
Statistical indicators supporting SCYNEXIS Inc.’s strength2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
How interest rate cuts could boost SCYNEXIS Inc. stockWeekly Market Summary & Stock Market Timing Techniques - newser.com
How strong is SCYNEXIS Inc. (135A) stock earnings growthWeekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
SCYNEXIS Inc. stock daily chart insightsPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Does SCYNEXIS Inc. fit your quant trading modelMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
Why SCYNEXIS Inc. (135A) stock could rally stronglyJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com
Regression analysis insights on SCYNEXIS Inc. performanceMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Trend analysis for SCYNEXIS Inc. this weekJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Has SCYNEXIS Inc. found a price floorJuly 2025 Update & High Accuracy Trade Alerts - newser.com
Technical signs of recovery in SCYNEXIS Inc.Stop Loss & Safe Entry Momentum Tips - newser.com
What momentum shifts mean for SCYNEXIS Inc.Bear Alert & Daily Entry Point Trade Alerts - newser.com
How SCYNEXIS Inc. stock reacts to Fed rate cuts2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
SCYNEXIS Inc. recovery potential after sell offJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
What data driven models say about SCYNEXIS Inc.’s futureJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):